hepatitis c
Cipla Launches Hepcvir-L For HepC Genotype 1 Patients
Hepcvir-L will be provided to patients in India at the fraction of the cost of branded Ledipasvir-Sofosbuvir under a licensing agreement with Gilead Sciences Inc.
Hepatitis C Tied To Parkinson’s Risk, Says Study
A nation-wide study in Taiwan has revealed a link between infection with hepatitis C and the development of Parkinson's disease.
How Hepatitis C Escapes Our Immune System
The hepatitis C NS3 protein plays an important role in subverting the host immune response to establish a chronic infection, scientists say.
Rapidly Detecting Drug-Resistant HepC
A nested PCR-based assay has been shown to rapidly and accurately detect drug-resistant strains of the hepatitis C virus.
Hydogels Help Hep C Drugs Go The Distance
Hydrogel delivery of PEGylated interferon could help reduce the frequency of treatment for hepatitis C patients to once every two months.
Making Pricey Pills Cheaper
Developing new drugs is undeniably expensive. Could big data and innovating funding mechanisms work together to make them more accessible to those who need it most?
Generic Hepatitis Drug Launched In India As Hepcvir
Generics manufacturer Cipla has been granted the license to produce Sofosbuvir in India under the brand name Hepcvir.
BMS Foundation Awards US$3.5 Million In Hepatitis Grants
Bristol-Myers Squibb has awarded US$3.5 million in grants to tackle the 'silent epidemic' of hepatitis in India and China.
HCV Genotype 1 Most Prevalent Worldwide
One third of the world's 83 million genotype 1 carriers reside in East Asia.
